S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 8, 2010
April 30, 2020
0d1f71ec-dd43-4c57-befe-2d7eb7e145f2
Related Documents
E2F Development Safety Update Report
Guidance DocumentAugust 23, 2011Center for Drug Evaluation and Research
Q8(R2) Pharmaceutical Development
Guidance DocumentNovember 20, 2009Center for Drug Evaluation and Research
E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers
Guidance DocumentMarch 1, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.